Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,16419413,flow rate,The mobile phase consisted of 0.1% formic acid in deionized water (60%) and acetonitrile (40%) at a flow rate of 0.5 mL/min.,Tissue distribution of loperamide and N-desmethylloperamide following a fatal overdose. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/16419413/),[ml] / [min],0.5,10347,DB01081,Diphenoxylate
,16419413,Heart blood concentrations,"Heart blood concentrations for loperamide and its metabolite were 1.2 mg/L and 3.3 mg/L, respectively.",Tissue distribution of loperamide and N-desmethylloperamide following a fatal overdose. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/16419413/),[mg] / [l],1.2,10348,DB01081,Diphenoxylate
,16419413,Heart blood concentrations,"Heart blood concentrations for loperamide and its metabolite were 1.2 mg/L and 3.3 mg/L, respectively.",Tissue distribution of loperamide and N-desmethylloperamide following a fatal overdose. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/16419413/),[mg] / [l],3.3,10349,DB01081,Diphenoxylate
not exceed,16419413,peak plasma concentrations,"In contrast, reported peak plasma concentrations of loperamide after administration of recommended daily doses of 16 mg did not exceed 0.012 mg/L in controlled trials.",Tissue distribution of loperamide and N-desmethylloperamide following a fatal overdose. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/16419413/),[mg] / [l],0.012,10350,DB01081,Diphenoxylate
,3682841,maximum level,Plasma diphenoxyllic acid levels rose to a mean (SE) maximum level of 87.8 (2.7) ng ml-1 3.3 (0.3) hr after dosing.,"The evaluation and application of a radioimmunoassay for the measurement of diphenoxylic acid, the major metabolite of diphenoxylate hydrochloride (Lomotil), in human plasma. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/3682841/),[ng] / [ml],87.8,49630,DB01081,Diphenoxylate
,3682841,levls,By 24 hr after dosing plasma levls had decreased to 14.26 (1.67) ng ml-1.,"The evaluation and application of a radioimmunoassay for the measurement of diphenoxylic acid, the major metabolite of diphenoxylate hydrochloride (Lomotil), in human plasma. ",Vss-Q65,[Article Link](https://pubmed.ncbi.nlm.nih.gov/3682841/),[ng] / [ml],14.26,49631,DB01081,Diphenoxylate
,3682841,appearance half-life,"The appearance half-life was calculated to be 0.82 (0.09) hr, and the elimination half-life was 7.24 (0.73) hr.","The evaluation and application of a radioimmunoassay for the measurement of diphenoxylic acid, the major metabolite of diphenoxylate hydrochloride (Lomotil), in human plasma. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/3682841/),h,0.82,49632,DB01081,Diphenoxylate
,3682841,elimination half-life,"The appearance half-life was calculated to be 0.82 (0.09) hr, and the elimination half-life was 7.24 (0.73) hr.","The evaluation and application of a radioimmunoassay for the measurement of diphenoxylic acid, the major metabolite of diphenoxylate hydrochloride (Lomotil), in human plasma. ","t1/2,Î²-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/3682841/),h,7.24,49633,DB01081,Diphenoxylate
